Longitudinal Outcomes and Neuroimaging of Fragile X Synd
Project Number5R01MH050047-11
Contact PI/Project LeaderREISS, ALLAN L
Awardee OrganizationSTANFORD UNIVERSITY
Description
Abstract Text
DESCRIPTION (provided by applicant): Fragile X syndrome (fraX) is the most
common known cause of inherited mental impairment with well over 100,000
individuals affected in the U.S. Mutations in the FMR1 gene give rise to a
clinical phenotype that includes increased risk for aberrant cognitive,
behavioral and emotional function. The major emphasis of the 5-year study
proposed in this application is a prospective, longitudinal extension o the
work completed during the current grant period, during which key cognitive,
behavioral, neuroendocrinological, genetic and environmental data were
collected from 120 families across the U.S. and Canada, each having a child
proband affected with fraX and a typically developing sibling. To the best of
our knowledge, this study would be the first longitudinal investigation of a
large, school-age fraX cohort in which both biological and environmental
factors contributing to clinical outcome were assessed on a prospective basis.
We also propose to extend our investigation into the neurobiology of this
disorder using advanced brain imaging techniques. Specifically, longitudinal
imaging studies will be used to explicate the developmental trajectory of brain
structure and function in children with fraX as compared to key control groups.
Specific Aims: 1) 10 use a longitudinal, prospective experimental design (with
"Time 1" and "Time 2? assessments) to elucidate the developmental trajectory of
cognitive, behavioral and emotional development in probands with fraX compared
to their like-gender siblings; 2) to specify the longitudinal trajectory of
hypothalamic-pituitary-adrenal (HPA) function and measures of FMR1 gene
expression in probands with fraX; and 3) to utilize neuromaging techniques to
specify the trajectory of brain structure and function in children with fraX
compared to specific age-, gender-, handedness-, SES- and lQ-matched control
groups. Although knowledge of cognition, behavior and the brain in children and
adults with fraX has grown considerably over the past 20 years, longitudinal
data from school-age children with this condition are limited. Cross-sectional
findings and limited longitudinal data to date support the hypothesis that an
age-related decline in standardized cognitive and adaptive behavioral scores
occurs among school-age children with fraX. However, many questions remain
unanswered regarding this phenomenon, in particular as related to extent,
timing and neural basis. These unanswered questions offer a compelling
rationale for conducting a longitudinal study of a large group of school-age
boys and girls with fraX as proposed in this application.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
adolescence (12-20)age differenceanxietyattention deficit disorderautismbehavioral /social science research tagbioimaging /biomedical imagingbrain imaging /visualization /scanningbrain morphologychild (0-11)child behaviorchild psychologyclinical researchcognitioncortisoldepressionfamily geneticsfamily structure /dynamicsfragile X syndromesfunctional magnetic resonance imaginggender differencegene expressionhandednesshuman subjecthypothalamic pituitary adrenal axisintelligencelongitudinal human studyoutcomes researchpathologic processsiblingssocioeconomics
No Sub Projects information available for 5R01MH050047-11
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01MH050047-11
Patents
No Patents information available for 5R01MH050047-11
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01MH050047-11
Clinical Studies
No Clinical Studies information available for 5R01MH050047-11
News and More
Related News Releases
No news release information available for 5R01MH050047-11
History
No Historical information available for 5R01MH050047-11
Similar Projects
No Similar Projects information available for 5R01MH050047-11